Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio
Two-stage exchange is most commonly used for treatment of prosthetic joint infections (PJI) but, this may fail to eradicate infections. C-reactive protein/albumin ratio (CAR) has been used to predict survival and operative success in other surgical subspecialties and so, we assess the association be...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Advances in Orthopedics |
Online Access: | http://dx.doi.org/10.1155/2019/6521941 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554668638601216 |
---|---|
author | Cierra S. Hong Sean P. Ryan Jonathan A. Gabor Michael A. Bergen Ran Schwarzkopf Thorsten M. Seyler |
author_facet | Cierra S. Hong Sean P. Ryan Jonathan A. Gabor Michael A. Bergen Ran Schwarzkopf Thorsten M. Seyler |
author_sort | Cierra S. Hong |
collection | DOAJ |
description | Two-stage exchange is most commonly used for treatment of prosthetic joint infections (PJI) but, this may fail to eradicate infections. C-reactive protein/albumin ratio (CAR) has been used to predict survival and operative success in other surgical subspecialties and so, we assess the association between CAR and reimplantation success during two-stage revision for PJI defined by the Musculoskeletal Infection Society following a primary total hip (THA) or knee (TKA) arthroplasty. From January, 2005 to December, 2015, two institutional databases were queried and patient demographics, antibiotic duration, C-reactive protein, and albumin were collected prior to reimplantation. Two-stage revisions were considered successful if patients were off of antibiotics and did not require a repeat surgery. CAR was available for 79 patients (34 hips and 46 knees) with 61 successful two-stage revisions and 18 failures. The average CAR for patients with successful reimplantation was 1.2 (0.2, 3.0) compared to 1.0 (0.4, 3.2) for treatment failure. However, this was not statistically significant (p=0.766). Therefore, CAR is not applicable in predicting the prognosis of two-stage revisions for PJI in total arthroplasty but other preoperative inflammatory-based prognostic scores should be explored. |
format | Article |
id | doaj-art-dbc529f3b8434ce68a51869105d5596f |
institution | Kabale University |
issn | 2090-3464 2090-3472 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | Advances in Orthopedics |
spelling | doaj-art-dbc529f3b8434ce68a51869105d5596f2025-02-03T05:50:54ZengWileyAdvances in Orthopedics2090-34642090-34722019-01-01201910.1155/2019/65219416521941Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin RatioCierra S. Hong0Sean P. Ryan1Jonathan A. Gabor2Michael A. Bergen3Ran Schwarzkopf4Thorsten M. Seyler5Duke University Medical Center, Durham, NC, USADuke University Medical Center, Durham, NC, USANYU Langone Health, New York City, NY, USADuke University Medical Center, Durham, NC, USANYU Langone Health, New York City, NY, USADuke University Medical Center, Durham, NC, USATwo-stage exchange is most commonly used for treatment of prosthetic joint infections (PJI) but, this may fail to eradicate infections. C-reactive protein/albumin ratio (CAR) has been used to predict survival and operative success in other surgical subspecialties and so, we assess the association between CAR and reimplantation success during two-stage revision for PJI defined by the Musculoskeletal Infection Society following a primary total hip (THA) or knee (TKA) arthroplasty. From January, 2005 to December, 2015, two institutional databases were queried and patient demographics, antibiotic duration, C-reactive protein, and albumin were collected prior to reimplantation. Two-stage revisions were considered successful if patients were off of antibiotics and did not require a repeat surgery. CAR was available for 79 patients (34 hips and 46 knees) with 61 successful two-stage revisions and 18 failures. The average CAR for patients with successful reimplantation was 1.2 (0.2, 3.0) compared to 1.0 (0.4, 3.2) for treatment failure. However, this was not statistically significant (p=0.766). Therefore, CAR is not applicable in predicting the prognosis of two-stage revisions for PJI in total arthroplasty but other preoperative inflammatory-based prognostic scores should be explored.http://dx.doi.org/10.1155/2019/6521941 |
spellingShingle | Cierra S. Hong Sean P. Ryan Jonathan A. Gabor Michael A. Bergen Ran Schwarzkopf Thorsten M. Seyler Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio Advances in Orthopedics |
title | Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio |
title_full | Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio |
title_fullStr | Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio |
title_full_unstemmed | Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio |
title_short | Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio |
title_sort | predicting success of two stage exchange for prosthetic joint infection using c reactive protein albumin ratio |
url | http://dx.doi.org/10.1155/2019/6521941 |
work_keys_str_mv | AT cierrashong predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio AT seanpryan predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio AT jonathanagabor predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio AT michaelabergen predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio AT ranschwarzkopf predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio AT thorstenmseyler predictingsuccessoftwostageexchangeforprostheticjointinfectionusingcreactiveproteinalbuminratio |